Multilayer Plasmon Hybridization in Au–Ag–Au Nanoparticles Enables Extinction Amplification in Transport-Limited One-Step Confirmatory Syphilis Biosensing
Ketan Dighe, Satheesh Natarajan, Maria Iftesum, Shraddha Krishnakumar, David Skrodzki, Matthew Molinaro, Nivetha Gunaseelan, Casey N. Pinto, Manas Ranjan Gartia, Dipanjan PanAbstract
Syphilis diagnosis requires pairing treponemal and non-treponemal antibody results, yet rapid tests combining both markers lose sensitivity at the low RPR titers (≤1:4) most critical in early infection and pregnancy. The limitation lies with the reporter: conventional gold nanoparticles (AuNPs) cannot generate high-contrast signals at low antibody concentrations without exceeding the diameter that allows capillary transport through a nitrocellulose membrane. Here, we report gold–silver–gold (Au–Ag–Au) multilayer plasmonic nanoparticles (ML-PNPs) that exploit interfacial plasmon hybridization to overcome this trade-off. Polyhedral 50–58 nm particles were prepared by seed-mediated growth followed by galvanic replacement, and their layered structure was confirmed by electron microscopy, elemental mapping, and X-ray photoelectron spectroscopy. A silver interlayer between chemically robust gold domains couples across two metal–dielectric interfaces, while the outer gold shell preserves colloidal stability and thiol-based bioconjugation at hydrodynamic diameters below 60 nm. Finite-difference time-domain (FDTD) simulations and hyperspectral imaging showed a broadened, red-shifted resonance (scattering maximum 658 nm vs 555 nm for AuNPs) with 18-fold enhanced absorption. In a dual-marker colorimetric lateral flow immunoassay (CLFIA), ML-PNPs improved the visual detection limit by 3-fold and required 6-fold fewer particles per visible test spot. Across 36 clinical specimens spanning RPR titers of 1:1 to 1:128, treponemal and nontreponemal test-line intensities increased by 19–46%, and low-titer 1:1 samples missed by AuNP strips were reliably detected, with full agreement with reference methods and no cross-reactivity with HIV-1 or HCV sera. Coupled with fingerstick sampling and on-strip plasma separation, this supports same-visit execution of the reverse testing algorithm in an instrument-free format.